Niche Biopharmaceuticals LLC
SHOREWOOD, MN · Founded 2020 · CIK 0001846144 · Biotech · Private
NB2, a coupled anti-infective immunomodulatory therapeutic molecule for dermatological and wound-healing indications
nichebiopharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $525K
- 4 Form D · May 2026
- 5 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 3 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $25,000 | |
| Private capital raised | Form D · SEC | $200,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $200,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2768 | Wave Bye Inc. | — | $852K |
| 2769 | DIAVACS, INC. | — | $850K |
| 2770 | OCEANYX PHARMACEUTICALS, INC. | — | — |
| 2771 | Niche Biopharmaceuticals LLC | — | $525K |
| 2772 | LACERTA THERAPEUTICS, INC. | — | $500K |
| 2773 | StaphOff Biotech, Inc. | — | $25K |
| 2774 | Arsenal Biosciences | — | $579M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Paul BrennanDirector
- Robert KlemDirector
- Dayton ReardanDirector · Executive Officer · Promoter
- Daniel SaccaniDirector
- Patrick SchlievertDirector
Patents
- Antimicrobial And Antiviral Sulfur Containing Glycerol Monoester Derivativesgranted
- Antimicrobial And Antiviral Sulfur Containing Glycerol Monoester Derivativesgranted
- Antimicrobial And Antiviral Sulfur Containing Glycerol Monoester Derivativesgranted
- Antimicrobial And Antiviral Sulfur Containing Glycerol Monoester Derivativesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.